This text focuses on the growth and promotion of the customary Chinese medicine (TCM) industry in Gansu province, China. HereS a breakdown of the key takeaways:
Economic Impact: The TCM industry is significant for local farmers, contributing 21% of their per capita disposable income, with Longxi County seeing 40% of that contribution. Investment & Growth: A recent Pharmaceutical Expo resulted in 68 cooperative projects worth 8.966 billion yuan and 38 procurement agreements totaling 4.669 billion yuan - a substantial injection of capital into the industry.
Strategic Focus: Gansu is prioritizing:
Secondary development of key medicinal materials (“Long Medicine”).
Transforming “Long Medicine” into new drugs.
R&D and production of health products (food, drugs, cosmetics) based on TCM.
Collaboration: The event fostered collaboration between Gansu and other regions/companies, notably Guangdong province and China Traditional Chinese Medicine Holdings Co., Ltd. and Guangzhou Pharmaceutical Group.these companies are committed to long-term partnerships and contributing to the growth of Gansu’s TCM industry.
Innovation & Technology: The expo highlighted the integration of technology into TCM, with a dedicated AI exhibition area showcasing diagnostic and treatment equipment.
Expert Input: Leading academics (including members of the Chinese Academy of Sciences and Engineering) provided insights on topics like drug targeting, planning techniques, and building a modern TCM public service system.
Goal: the overarching goal is to elevate gansu’s TCM industry to a globally recognized standard and contribute to the “healthy China” initiative.
In essence,the text paints a picture of a province actively investing in and modernizing its TCM industry,seeking partnerships,and leveraging technology to unlock its full potential.
